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Abstract: Forty Nelore cows were submitted to timed artificial insemination (TAI) protocol and randomly assigned to groups according
to estradiol (E2) ester (cypionate or benzoate, i.e. EC or EB) and equine chorionic gonadotrophin treatment (eCG or No-eCG) in a
factorial 2x2 design. On a random day of the estrous cycle (Day 0), cows received a P4 intravaginal device plus 2 mg im injection of EB.
At the time of P4 device removal (Day 8), cows were treated with 0.150 mg im of D-cloprostenol (PGF) and randomly divided to receive
or not 400 UI im of eCG, as well as randomly assigned to receive 1 mg of EC immediately (D8), or 1 mg of BE, 24 h after it (D9) as
ovulatory stimuli. Therefore, the groups formed were EC, EC+eCG, EB and EB+eCG. Were evaluated the effects of treatments on VEGF,
OXTR, and PGR gene expression, E2/P4 concentrations, and Doppler-flowmetry of the reproductive tract of the investigated models.
Ovulation rate was higher in animals subjected to the EC + eCG treatment (p < 0.05). Follicular vascularization was not influenced by
the ovulation inducer (p > 0.05), although it was influenced by the eCG treatment (p < 0.05). EB enabled higher vascularized area rate in
CL (P = 0.0192). VEGF and PGR genes were more expressed in animals treated with EB and eCG. On the other hand, OXTR expression
was less evident in eCG-treated cows. EC has led to higher E2:P4 ratio in follicular fluid. This outcome indicated higher follicular
estrogenic activity at D10, which justified the higher ovulation rate, when EC was associated with eCG (p < 0.05). Finally, the results of
the present study corroborate the hypothesis that the different E2 esters and eCG differentially regulate vascularization, steroidogenesis,
and utero-ovarian gene expression in Bos indicus cows submitted to TAI protocols.
Key words: Timed artificial insemination, estradiol ester, gonadotrophin, genes, ultrasoun

1. Introduction
Reproductive efficiency is the trait that mostly influences
commercial cattle herds’ productivity and profitability. The
programmed use of reproductive hormones, and of their
analogues in timed artificial insemination (TAI) protocols
is the main strategy adopted to increase the service rate
of cows in reproduction processes. This procedure allows
synchronizing both the ovulation and insemination of
all females available for reproduction. However, mean
fertilization rates at the first artificial insemination
procedure have historically reached 50% [1,2], and it
indicates that a significant number of inseminated females
failed to get pregnant.
Different strategies have been suggested to help
improving the effectiveness of synchronization techniques

applied to TAI. Among them, one finds the use of equine
chorionic gonadotropin (eCG) to stimulate preovulatory
follicle growth, increase progesterone (P4) corpus luteum
(CL) production, and improve pregnancy rates [3–5]. In
addition, estradiol benzoate (EB) is administered at the
early protocol application stage in order to induce atresia
in developing follicles, and it leads to the emergence of new
follicular wave [6]. More recently, estradiol cypionate (EC)
has been widely used at intravaginal device removal time
in order to induce LH peak between 45 and 49 hours, as
well as ovulation between 67 and 70 h after treatment [7].
The use of these exogenous hormones in TAI protocols
leads to differential gene expression in bovine endometrium
[8]. Genomic effects of steroid hormones, estradiol (E2),
and P4 on the endometrium are mainly mediated by their
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connection to their receptors [9,10]. Among the genes
of importance in this context, one finds VEGF (vascular
endothelial growth factor), OXTR (oxytocin receptor),
and PGR (progesterone receptor), which are associated
with angiogenesis, follicular and uterine development
[11,12], as well as with uterine receptivity for embryonic
implantation [13–15].
Changes in P4 serum concentrations at early luteal
stage can lead to temporal variations in the composition
and number of transcripts in bovine endometrium [16,17].
E2 increases the expression of its own receptors, as well as
of PGR and OXTR in the endometrium [9,18,19].
In addition, exogenous hormones are capable of
modulating the blood vascular pattern in animals’
reproductive tract [20,21]. The uterus of female cattle, as
well as of other species, undergoes physiological changes
throughout the estrous cycle, and each cycle stage is
directly linked to uterine vascular perfusion [22,23].
These changes are regulated by steroidal hormones and by
a network of complex interactions between local growth
factors secreted by the uterine epithelium and stroma
[23–25].
E2 is a steroidal hormone known for its vasodilatory
effect [26,27], whereas P4 increases uterine receptivity
to the embryo through the induction of endometrial
angiogenesis [28]. Some studies have emphasized the
influence of eCG administration on CL formation and
vascularization, as well as on P4 production and increased
uterine blood flow, both in embryo recipients and donors
[29–31].
Thus, gene expression and blood vascular pattern
in the reproductive tract can be regulated by exogenous
hormones used in TAI protocols. Therefore, the aim of the
current study was to analyze the influence of hormonal
protocols on hemodynamics and gene expression, which
are directly linked to follicles’ ovulatory capacity, CL
development, gonadal steroidogenesis, and associated
endometrial responses.
2. Materials and methods
2.1 Study site and animals
The current study was carried out in a commercial
farm in Barra do Corda County, Maranhão State, Brazil
(latitude 5°30`21” South and longitude 45°14`34” West).
Animal models were kept in an extensive breeding
system comprising Mombasa grass pasture (Megathyrsus
maximus), mineral supplementation, and water ad libitum.
The experiment comprised 40 multiparous lactating
Nelore (Bos indicus) cows, at mean age 48.0 ± 0.0 months,
in anestrus, with postpartum period ranging from 35 to 60
days, and body condition score (BCS) of 3.0 ± 0.0, based
on Machado et al. [32].

Experimental procedures were approved by the Ethics
Committee on Animal Research of Federal University
of Maranhão (CEUA-UFMA), under Protocol N.
23115.014522/2020-37.
2.2 Experimental design
Nelore cows were submitted to timed artificial
insemination (TAI) protocols and randomly assigned to
groups according to E2 ester (EC or EB) and eCG treatment
(eCG or No-eCG) in a factorial 2 x 2 arrangement (Figure
1). The experiment followed a complete randomized block
design (RCBD). For grouping the experimental units
into homogeneous groups or blocks based on similar
ovulatory potential, the cows were stratified according to
the dominant follicle diameter at P4 device removal time
(D8; day 18 of protocol application) and allocated to 4
treatments with 10 cows each.
2.3 Hormonal protocol
At the start of the study (designated Day 0), all cows were
given a intravaginal P4 device (1 g of P4; Sincrogest®,
Ourofino, São Paulo, Brazil) and 2 mg of EB im (EB;
Estrogin, Farmavet, São Paulo, Brazil). On Day 8, P4
devices were removed, and cows received 0.150 mg of
D-cloprostenol im (PGF; Prolise, Arsa, Buenos Aires,
Argentina). At this time (D8), the cows were randomly
divided to receive or not 400 UI of eCG im (SincroeCG,
Ourofino, São Paulo, Brazil), as well as randomly assigned
to receive 1 mg of EC (ECP, Zoetis Saúde Animal, São
Paulo, Brazil) immediately (D8), or 1 mg of BE, 24 h after
it (D9) (Figure 1). Therefore, the groups formed were
EC (n=10), EC + eCG (n=10), EB (n=10) and EB + eCG
(n=10).
2.4 Ultrasound evaluations
Animals were subjected to 5 ultrasound evaluations
at protocol application days 0, 8, 9, 10, and 18 (Figure
1); these evaluations were performed with the aid of
an ultrasound device (Mindray, Model Z5Vet, Digital
Ultrasonic Diagnostic Imaging System) equipped with 7.5
MHz transrectal linear multifrequency transducer.
The examination was initially performed in
bidimensional mode (B-mode; grayscale) in order to
identify the uterine-ovarian structures and measure the
diameters of the dominant follicle (DF) and the corpus
luteum (CL). Next, Color-Doppler mode was activated
to determine the blood perfusion area in the structures;
images were recorded for further analysis (Figure 2).
One-minute-long real-time continuous cross-section
scanning of uterine horns and ovaries was recorded in
order to show the largest blood

perfusion area possible
with a better quality image (adapted from Ferreira et al.
[33]). The vascular perfusion area (in color) proportional
to the total area of uterus and ovaries (0 to 100%) was
subjectively assessed by six appraisers. The maximum and
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Figure 1. Schematic view of TAI protocol and proceedings following ovulation synchronization in Nelore (Bos
indicus) cows subjected to an P4/E2-based timed artificial insemination (TAI) protocol using EC or EB as ovulatory
stimuli and its association, or not, with eCG. †, † TAI protocol. On a random day of the estrous cycle (Day 0), cows
received a P4 intravaginal device plus 2 mg im injection of EB. At the time of P4 device removal (Day 8) cows
were treated with 0.150 mg im of D-cloprostenol (PGF) and randomly divided to receive or not 400 UI im of
eCG; as well as randomly assigned to receive 1 mg of EC immediately (D8), or 1 mg of BE, 24 h after it (D9). US
B-mode = ultrasound examination in bidimensional mode (grey-scale); DOPPLER = ultrasound examination in
Color-Doppler mode; EC = estradiol cypionate; EB = estradiol benzoate; OPU = ovum pickup / ultrasound-guided
aspiration of follicular fluid in vivo; P4 device = Sincrogest

minimum scores were discarded, whereas the median
scores were used. Objective evaluations were performed
based on the intensity of the colored images (in number of
pixels), as previously described for mares and heifers [34–
36]. The number of colored pixels in the analyzed images
was counted in image editing software (Adobe Photoshop
CS5) in order to measure the extension of the uterine horn,
ovary, follicular wall, and corpus luteum vascularization at
pixel scale [37] (Figure 2).
2.5 Follicular fluid recovery in vivo
Dominant follicle aspiration was carried out at the end of
the synchronization protocol (D10) - which corresponded
to TAI time – to enable follicular fluid recovery in vivo,
which was guided by ultrasound equipped with a guiding
device for the Ovum Pickup 10-gauge needle. Follicular
content was recovered through aspiration, based on the
application of manual negative pressure, via Teflon circuit
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8
8 PM

(Wtavet, Brazil) - 2 mm in internal diameter and 80 cm in
length - connecting the needle directly to a 10 mL syringe.
2.6 Uterine biopsy
Uterine endometrium sample was collected at follicular
aspiration time (D10). It was removed from the region of
the middle curvature of the uterine horn ipsilateral to the
ovulatory follicle, with the aid of Yomann forceps, through
transcervical access. Next, collected fragments were stored
in RNALater (Ambion, Austin, USA) at –20 °C, until
mRNA extraction, reverse transcription, and real-time
PCR at the laboratory.
2.7 RNA extraction and cDNA synthesis
Total mRNA was extracted by using the RNeasy Micro
Kit (Qiagen GmbH, Hilden, Germany), according to
the manufacturer’s specifications, and treated with
Dnase. Total RNA in 1 μL of the sample was quantified
through spectrophotometry with the aid of ND-100
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1
Figure 2. Uterine ultrasonography showing blood flow in Color Doppler mode (A) and the same structure in B-mode (B).
The image of the CL in Color Doppler mode (C) and the same image edited by Adobe Photoshop CS5 for color pixels count
(D).

spectrophotometer (NanoDrop, Wilmington, USA). The
mRNA was retrotranscribed into cDNA by using the
Super Script III First-Strand Synthesis System commercial
kit for RT-PCR (Invitrogen, Carlsbad, CA, USA), for the
final volume reaction of 20 μL. In addition, 3.0 μL of DEPC
water, 1.0 μL of Random Hexamer (50 μg / μL), 1.0 μL of
Anneling Buffer, 2.0 μL of RNase OUTTM Enzime Mix,
10.0 μL of 2x First were used for cDNA synthesis -Strand
Reaction Mix. The following parameters were used for
cDNA synthesis: 65 °C for 5 min, incubation in ice for 1
min, 25 ºC for 10 min, and 50 ºC for 50 min. Subsequently,
cDNA was subjected to conventional PCR to assess
whether the amount of RNA was enough or not. Samples
were subjected to electrophoresis in 2% agarose gel, right
after PCR, in order to confirm fragment size.
2.8 Quantitative real-time RT-PCR (RT-qPCR)
RT-qPCR was performed based on 2.5 μL of cDNA, 10
μM of primer pair specific to each gene, and 12.5 μL of
Platinum SYBR Green qPCR SuperMix (Platinum SYBR
Green qPCR SuperMix - with ROX, Invitrogen) at final
volume of 20 μL per reaction. The following parameters
were used for RT-qPCR: 50 ºC for 2 min, 95 ºC for 10
min, 40 cycles of 95 ºC for 15 s and 60 ºC for 1 min; RT-

qPCR was conducted in ABI 7500 thermocycler (Applied
Biosystems). Data were analyzed based on the comparative
Ct method [38]. Ct values were normalized based on
GAPDH expression. The sequence of used primers is
described in Table 1.
2.9. E2 and P4 concentrations in follicular fluid and
blood plasma
Blood samples were collected after each ultrasound
evaluation in order to determine serum concentrations
of ovarian steroid hormones such as P4 and E2. In order
to do so, animals’ caudal vein was punctured, and blood
was directly collected in 10 mL Vacutainer vacuum tubes,
without anticoagulant (Becton-Dickinson & Company,
USA), at room temperature. Each sample was centrifuged
(3000 g for 10 min; Excelsa Baby Centrifuge, Fanem,
Brazil) right after collection; the serum was separated
from the sample, labeled, and stored in sterile tubes at –20
°C. Samples were diluted in PBS to adapt to the standard
curve of the quantification kit to enable determining the
steroid hormone (P4 and E2) concentrations in follicular
fluid. The dilution was performed due to high E2 (dilution
ratio 1:100) and P4 (dilution ratio 1:50) concentrations in
follicular fluid.
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Table 1. Sequence of genes and primers used in RT-qPCR.
Gene

Tissue / associated function

Primers (5’-3’)

NCBI sequence of reference

GAPDH

Endogenous Gene of reference

5’- GAGCTTGACAAAGTGGTCGTTGAG-3’
3’-CCAACGTGTCTGTTGTGGATCTGA-5’

NM_001034034.1

PGR

Endometrial gene

5’-GCCGCAGGTCTACCAGCCCTA-3’
3’-GTTATGCTGTCCTTCCATTGCCCTT-5’

NM_001205356.1

VEGF

Endometrial gene

5’-GCCATGGAGCGCTTTGG-3’
3’-CCACAGTCAGCAATGGTGATCT-5’

NM_174216

OTR

Endometrial gene

5’-AAGATGACCTTCATCGTCGTG-3’
3’-CGTGAAGAGCATGTAGATCCAG-5’

NM_174134.2

Analyses were based on the immunoenzymatic assay
technique (ELISA); they used commercial kits to determine
progesterone and estradiol in solid phase (Progesterone
ELISA and 17beta-Estradiol ELISA kit, IBL International).
2.10 Statistical analysis
Data analysis was performed in the Statistical Analysis
System for Windows SAS software (version 9.4. SAS Inst.
Inc., Cary, NY, USA). The normality of residues for each
variable was analyzed through Shapiro–Wilk test (SAS
PROC UNIVARIATE application). Whenever necessary,
data were transformed (logarithm in base 10 - Log10
X) to meet the assumptions of the analysis of variance.
Continuous dependent variables (follicular diameter and
pixels) were subjected to ANOVA and expressed as mean
and standard error of the mean (mean ± SEM), whereas
means between treatments were compared by Duncan
test (PROC GLM from SAS). Ovulation rate was featured
at D18, based on the identification of corpus luteum
formed after the luteinization of the dominant follicle
aspirated at D10 [39], and analyzed through Fisher’s exact
test (GraphPad Instat) [40]. Hormonal concentrations,
follicular vascularization area, and mRNA expression
for PGR, VEGF, and OXTR genes have shown nonnormal distribution; the model was adjusted for Poisson
distribution, and they were analyzed through Poisson
regression (PROC GLIMMIX from SAS), based on Wang
et al. [41] and Svensson et al. [42].
The association between variables was investigated
based on the Principal Component Analysis (PCA)
method in Statistica 7.1 software [43]. According to the
aforementioned method, the two produced axes graphically
represent the strongest data pattern, i.e. it explains the
important role played by the two main components in
total data variation. The significance level to reject H0
(null hypothesis) was 5%, i.e. a significance level lower
than 0.05 indicated the effect of the classificatory variables
and of the interactions between them.
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3. Results
Dominant follicle and corpus luteum diameter did not
differ among treatments (p > 0.05). Ovulation rate was
significantly higher in animals subjected to the EC +
eCG treatment than in those subjected to EC (p < 0.05).
Groups treated with EB did not show the effect of eCG
on ovulation rate, whereas groups treated with EC and
E + eCG have shown intermediate ovulation rate (p >
0.05). Overall, there was no interaction between inducers
and eCG (Inducer x eCG) in DF and CL diameters or in
ovulation rate (Table 2).
There was no significant difference in 
uterine
vascularization area at D8 among treatments (p >
0.05). However, there was an effect of both EC and eCG
administration, which significantly increased uterine
vascularization, from D8 to D9 (P = 0.0006) (Table 3).
The ovulation inducer did not have an effect on DF wall
vascularization; however, eCG administration presented
a significant interaction with E2 ester, as it increased DF
vascularization only on D8 for EC and only on D9 for EB
(E2 x eCG interaction = 0.0019 on D8 and = 0.0058 on D9)
(Table 3). This finding has shown that the best vascular
response of the inducer in the current study depended on
its association with eCG and on its administration time
(D8 for EC and D9 for EB).
Cows treated with EB recorded a higher vascularized
area rate both in CL (P = 0.0192) and in the uterus (p =
0.0315), in the diestrus subsequent to protocol application
(D18). On the other hand, there was no effect or interaction
of EB with eCG (p > 0.05) (Table 3).
Animals treated with EC recorded higher E2:P4 ratio
(Figure 3) in the follicular fluid collected at protocol
application D10 (dominant preovulatory follicle).
Surprisingly, this association was lower in groups treated
with eCG. On the other hand, eCG had a positive effect
on P4 concentration increase in the subsequent diestrus
(D18), particularly when it was associated with EC. Serum
estradiol concentrations at D18 were similar to each other,

FRANÇA et al. / Turk J Vet Anim Sci
Table 2. Effects of estradiol esters (EB and EC) as ovulatory stimuli and its association, or not, with eCG, on the ovarian follicular
response in Nelore (Bos indicus) cows evaluated by ultrasound at days 8, 9, 10, and 18 of a P4/E2-based timed artificial insemination
(TAI) protocol. †

Variable

EB

P-value

EC

eCG

No eCG

eCG

No eCG

E2

eCG

E2 x eCG

n

10

10

10

10

-

-

-

DF diammeter at D8 (mm)

10.2 ± 0.8

10.3 ± 0.8

9.7 ± 0.6

9.9 ± 0.8

0.5273

0.8571

0.9521

DF diammeter at D9 (mm)

11.5 ± 0.7

10.8 ± 0.8

11.7 ± 0.6

10.7 ± 0.9

0.9071

0.2990

0.8914

DF diammeter at D10 (mm)

12.1 ± 0.7

12.2 ± 0.8

13.3 ± 0.6

11.8 ± 0.8

0.6058

0.4059

0.3047

CL diammeter at D18 (mm)

17.4 ± 1.3

17.0 ± 1.4

15.5 ± 2.9

15.2 ± 3.1

0.3290

0.3956

0.3936

Ovulation rate*

70% (7/10)

0.1000

0.2700

---

ab

80% (8/10)

ab

100% (10/10) 50% (5/10)
a

b

†

TAI protocol. On a random day of the estrous cycle (Day 0), cows received a P4 intravaginal device plus 2 mg im injection of EB. At
the time of P4 device removal (Day 8) cows were treated with 0.150 mg im of D-cloprostenol (PGF) and randomly divided to receive
or not 400 UI im of eCG; as well as randomly assigned to receive 1 mg of EC immediately (D8), or 1 mg of BE, 24 hours after it (D9).
* Ovulation rate; featured by the identification of corpus luteum at D18; analyzed through Fisher’s exact test.
ab
Means followed by different superscripts on the same line significantly differ from each other, based on the Duncan test, at 5%
significance level.
EB = estradiol benzoate; EC = estradiol cypionate; eCG = equine chorionic gonadotropin; DF = dominant follicle
Table 3. Effects of estradiol esters (EB and EC) as ovulatory stimuli and its association, or not, with eCG, on the uterovarian vascular
response in Nelore (Bos indicus) cows evaluated by Color Doppler ultrasonography at days 8, 9, 10, and 18 of a P4/E2-based timed
artificial insemination (TAI) protocol. †

Variables

EB

P-value

EC

eCG

No eCG

eCG

No eCG

E2

eCG

E2 x eCG

n

10

10

10

10

-

-

-

Uterine vascularization area at D8 (%)

9.8 ± 0.9

11.9 ± 1.0

12.3 ± 1.1

11.9 ± 1.0

0.2334

0.3958

0.2334

Uterine vascularization area at D9 (%)

18.0.9 ± 1.3a 10.7 ± 1.3b

19.7 ± 3.9a

18.2 ± 3.3a

0.0006

0.0008

0.0117

Uterine vascularization area at D10 (%)

16.3 ± 1.3

19.9 ± 1.5

17.6 ± 1.0

b

15.5 ± 1.2

0.2714

0.6443

0.0420

Uterine vascularization area at D18 (%)

15.8 ± 1.2a

12.4 ± 1.2ab

11.4 ± 1.1b

11.5 ± 1.1b

0.0315

0.2120

0.1800

DF vascularization area at D8 (%)

12.1 ± 1.1

11.6 ± 1.0

16.9 ± 1.3

8.7 ± 0.9

0.8035

0.0005

0.0019

DF vascularization area at D9 (%)

15.5 ± 1.2a

10.7 ± 1.0b

10.9 ± 1.0b

12.8 ± 1.1ab

0.3461

0.2540

0.0058

DF vascularization area at D10 (%)

15.0 ± 1.2

10.3 ± 1.0

11.2 ± 1.1

10.9 ± 1.0

0.2231

0.0384

0.0740

CL vascularization area at D18 (%)

40.0 ± 2.5a

43.5 ± 2.3a

32.5 ± 1.8b

38.7 ± 3.1ab

0.0192

0.0549

0.4816

ab

b

a

a

bb

b

ab

a

b

c

b

†

TAI protocol. On a random day of the estrous cycle (Day 0), cows received a P4 intravaginal device plus 2 mg im injection of EB. At
the time of P4 device removal (Day 8) cows were treated with 0.150 mg im of D-cloprostenol (PGF) and randomly divided to receive
or not 400 UI im of eCG; as well as randomly assigned to receive 1 mg of EC immediately (D8), or 1 mg of BE, 24 hours after it (D9).
ab
Means followed by different superscripts on the same line significantly differ from each other, based on the Duncan test. at 5%
significance level. EB = estradiol benzoate; EC = estradiol cypionate; eCG = equine chorionic gonadotropin; DF = dominant follicle.

regardless of the adopted treatment (p > 0.05) (Figures 3
and 4).
Overall, EB has induced greater endometrial
expression of the investigated genes (p < 0.0001; Figure
5). E2 esters and eCG had isolated effect on VEGF-

system gene expression, which was significantly higher in
animals treated with EB (p < 0.0001), eCG (p < 0.0140)
and its association (EB + eCG; p < 0.05) (Figures 5 and 6).
There was also high OXTR gene expression in the group
treated with EB (p < 0.0001), although its expression was

33

FRANÇA et al. / Turk J Vet Anim Sci

100

105

110

115

E2 (pg/mL)
125
130

120

135

140

145

150

155

E2

*

†

E2:P4

*

P4

0

5

10

15

20

eCG

25
30
P4 (ng/mL)

No eCG

EC

35

40

45

50

EB

1
Figure 3. Main effects of estradiol esters (EB and EC) as ovulatory stimuli and eCG administration, on the P4 and E2 concentrations
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2 mg im injection of EB. At the time of P4 device removal (Day 8) cows were treated with 0.150 mg im of D-cloprostenol (PGF) and
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of BE, 24 h after it (D9). Values are expressed as mean ± SEM. * Significant difference between eCG vs No eCG (p < 0.05). † Significant
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Figure 4. Effects of treatments with estradiol esters (EB and EC) as ovulatory stimuli and its association, or not, with eCG, on the P4
and E2 concentrations in blood serum (D18) and on E2:P4 ratio in follicular fluid (D10) of Nelore (Bos indicus) subject to an P4/
E2-based timed artificial insemination (TAI) protocol. †, †TAI protocol. On a random day of the estrous cycle (Day 0), cows received
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less evident in animals treated with eCG. The CE + eCG
group has shown the lowest OXTR expression among
treatments (Figures 5 and 6). PGR gene expression was
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also significantly higher in groups treated with BE (p <
0.0001) and the use of eCG had a positive influence on
the expression of this gene, regardless of the inducer (p

FRANÇA et al. / Turk J Vet Anim Sci
< 0.0001). This finding has shown that increased PGR
expression depends on the use of eCG in association with
inducers (p = 0.0002) (Figures 5 and 6).
The association between variables analyzed through
Mode-B ultrasonography, uterine-ovarian Color-Doppler,
ovarian steroids serum concentration, and uterine gene
expression was investigated through Principal Component
Analysis (PCA) (Figure 7). Results have shown that the
two main components, altogether, explained 40.21% of
total data variation. Ovulation rate (OVU), OXTR, and
PGR were the most representative variables in Component
1, since they presented longer-length vectors that were
closer to the Component 1 axis. DF vascularization (DFV)

450.000
450
400.000
400

ESTRADIOL
ESTER
INDUTOR
†

and follicular E2 concentration (E2) were the variables
that mostly contributed to Component 2; they were highly
related to each other, but they were not related to OXTR
and PGR. VEGF expression and uterus vascularization
(UTV) have shown strong association with each other,
since they formed acute angles between their respective
vectors, as shown in Figure 7.
4. Discussion
Although the current study did not find a difference in
follicular diameter among experimental groups, the use
of inducers in association with eCG has influenced the
higher ovulation rate observed for the CE + eCG group
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(100%). This outcome was already expected, since many
other studies have shown that eCG leads to increased
fertilization rate because it makes the LH preovulatory
peak more consistent, as well as increases dominant
follicles’ responsiveness to ovulation inducers and increases
ovulation rate, mainly in anestrous animals [30, 44–52]. In
addition, according to Sá Filho et al. [53], EC accounts for
increasing the incidence of estrus and for better pregnancy
rates after AI than EB.
These results have shown that, despite the divergence
of information about the synchronization capacity of
ovulations induced by EC administration at P4 device
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CE

CE

removal time, the use of this ovulation inducer resulted in
fertilization rates similar to, or better than, those recorded
for BE, in insemination procedures performed 48h [54,55],
between 52 and 56 h [56] and between 54 and 58h [57]
after P4 removal. This outcome was mainly observed when
EC was used in association with eCG, which has enhanced
synchronization and luteinization, besides stimulating
follicular development [58].
Thus, EC administration at the P4 device removal day
(three management protocol; Torres-Júnior et al. [59])
has been widely used to replace BE as ovulation inducer,
without compromising indices recorded for progesterone
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Figure 7. Biplot2of principal component analysis (PCA) applied to the association between variables, based on B-mode and Doppler
ultrasonography, sex steroid concentrations in follicular fluid and uterine gene expression in Nelore cows (Bos indicus) subjected to
synchronization protocol with different estradiol esters and eCG. OVU = ovulation rate; DF = dominant folicle diammeter; DFV =
dominant follicle vascularization; UTV = uterine vascularization; E2 = estradiol concentrations in follicular fluid; P4 = progesterone
concentrations in follicular fluid; VEGF = endometrial expression of vascular endothelial growth factor gene; OXTR = endometrial
expression of oxytocin receptor gene; PGR = endometrial expression of progesterone receptor gene.

plus eCG-based protocols. Thus, EC is an alternative used
to simplify synchronization programs, since it enables
reducing the number of times animals should be managed
without affecting synchronization treatment effectiveness,
mainly in large herds [56,57,60,61].
Endometrial blood vascularization is an important
factor in uterine receptivity to the fetus [62]. The
vascularized uterine area rate (%) observed in the current
study has changed among treatments, from 24 h after P4
device removal onwards (D9). It may have happened due
to decreased P4 concentration after P4-device withdrawal
and to animals’ sequential exposure to E2, which have led
to vasodilation and, consequently, to increased uterine
vascular flow [63]. Another recent study has shown
that dairy cows subjected to 10 mg of intramuscular EB
application during the postpartum period, as well as
to color Doppler ultrasound assessment, have shown
increased blood flow volume and speed, as well as uterine
artery diameter [64].
The action of eCG in increasing uterine blood flow
was also notable in the current study, mainly when it was
associated with EB. The use of gonadotropins such as FSH,
hCG, or eCG in TAI protocols has increased follicular
estradiol concentrations [65]; estradiol worked as an

important vasodilator in the uterine artery [26,66]. In
addition, other studies have positively correlated increased
uterine blood flow to estrogen levels during estrus in cows
[20,21,67]. Honnens et al. [31] observed increased blood
flow volume and decreased uterine artery pulsatility index
in a study conducted with cows subjected to superovulation
treatment with gonadotropins.
Animals treated with one of the estradiol esters, either
with benzoate or cypionate, did not show changes in the
blood vascular pattern of DF, when they were not subjected
to concomitant eCG application. However, each ovulation
inducer, used in association with eCG, has induced vascular
flow increase in DF, at its respective administration day (EC
at D8 and EB at D9). The group treated with EB presented
a permanent vascularization increase from D9 to D10; this
outcome was likely influenced by increased intra-follicular
E2 concentrations in this group in comparison to the one
treated with EC. It may have happened in response to the
increased pharmacological bioavailability of EB. Vynckier
et al. [68] have observed a fast increase in E2 level in the
blood plasma of Holstein cows treated with 10 mg of EB;
the maximum E2 level was recorded between 1 and 23 h
after EB application. On the other hand, these very same
authors have observed later peak plasma E2 concentrations,
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after EC administration. A similar outcome was reported
by Sales et al. [7], who observed LH peak approximately 30
h after EC administration and area under the curve twice
as persistent in comparison to that of EB (8.6 ± 0.2 vs 16.5
± 1.0; p < 0.05) [7].
Blood vascularization at follicle margin throughout
proestrus and estrus is quite discreet; it presents noticeably
increased blood flow approximately 6 hours before the
beginning of the LH peak [69]. Interestingly, Ginther
[35] has shown that color Doppler does not detect blood
flow signs in follicles that do not ovulate, even if they
have preovulatory diameter. This outcome indicates the
potential of the Color-Doppler tool to assess blood flow
in dominant follicles in TAI protocols, as long as vascular
effects inherent to the administration time, dose, and
estradiol ester used to induce ovulation are also taken into
consideration at test interpretation time [20]. Ovulatoryfollicle wall collapses during ovulation. In addition,
angiogenic and mitogenic factors such as insulin-like
growth factor, fibroblast growth factor, and endothelial
vascular growth factor (VEGF) under LH influence lead
to corpus luteum growth and vascularization [70]. Groups
treated with EB have formed more vascularized CLs in the
diestrus subsequent to protocol application (D18). It may
have happened due to higher VEGF gene expression in
this group.
A positive correlation between CL vascularization
and P4 production was previously described by Arruda
[71] and Ginther et al. [72]. However, the use of eCG in
the current study has increased P4 concentrations, but
it did not influence CL vascularization. On the other
hand, the EB-treated group presented a larger number
of vascularized CLs, but it did not present increased P4
concentrations. In addition, it is important emphasizing
that, despite the different CL vascularization patterns
observed among estradiol esters, its diameter remained
unchanged.
According to Bollwein et al. [23], there was no
association between CL diameter and changes in blood flow.
This outcome has suggested that CL neovascularization
process was not associated with its dimension. Blood
flow has increased in parallel with increased circulating
progesterone concentration at the early CL development
stage; thus, vascularization was associated with the
potential to produce progesterone [73].
As in CL, uterine vascularization at D18 (diestrus)
was significantly higher in the EB group; therefore, it did
not follow the expected negative correlation pattern often
observed between both. The presence of CL influences
uterine resistance (IR) and pulsatility (IP) rates, which are
often higher in animals without CL, thus indicating lesser
blood perfusion [35,74]. Similar results were observed
by Rawy et al. [64] in study conducted with dairy cows
subjected to 10 mg of intramuscular EB application during

38

the postpartum period. Animals were evaluated with the
aid of color Doppler ultrasound, which showed increased
blood flow volume and speed, as well as uterine artery
diameter.
According to Hervé et al. [75], the variability in VEGF
system expression is associated with functional changes in
animals’ uterus and ovaries. Among the factors accounting
for increasing VEGF expression, one finds ovarian steroid
hormones [76] and prostaglandins [77]. VEGF expression
in the diestrus subsequent to protocol application in the
current study was significantly higher in animals treated
with EB, and it may also explain the greater uterine
vascularization observed at the same time. Therefore,
the vascular effects of P4 resulted from its stimulatory
action in VEGF production [78–81]. VEGF is highly
mitogenic to endothelial cells [82]. This protein accounts
for inducing endothelial cell proliferation, maturation,
and migration, as well as for inhibiting apoptosis. VEGF
regulates angiogenesis, blood vessel permeability [83], as
well as vascular development under normal [84,85] and
pathological conditions [86].
In addition, the BE + eCG group presented higher
VEGF expression, which enabled inferring that the effects
of the stimulation treatment with eCG have changed
gene expression in the uterus in the short-term and,
consequently, they modulated the blood perfusion pattern.
VEGF expression can also be regulated by ovarian steroid
hormones [76], prostaglandins [77], FSH [87], hCG [88],
or by eCG itself [89], although eCG did not influence
VEGF expression in the group treated with EC.
The EB group has also recorded higher OXTR gene
expression, despite the fact that it presented a lower E2:P4
ratio than that of animals treated with EC. However, the
EB group recorded higher absolute E2 concentration in
follicular fluid than that of EC (1,637.50 ± 14.3 vs 1,500.00
± 12.3 pg/mL; p < 0.05). Periovulatory E2 variations, as
well as their interrelation with P4, are known to stimulate
endometrial contractions mediated by increased oxytocin
bonds to their receptor [9,90,91].
The PGR gene was more expressed when eCG was used
in the protocols. This finding was again in compliance with
the higher P4 concentration found in both follicular fluid
(D10) and blood serum (D18). According to Souza et al.
[92], eCG promotes increase in the number of luteal cells,
which account for approximately 80% of P4 synthesis
and give it greater volume and steroidogenic capacity.
Accordingly, Baruselli et al. [93] have indicated eCG use
as a potential tool to improve plasma P4 concentrations
in estrous cycles subsequent to TAI protocol applications.
These data have shown eCG effectiveness in increasing
ovulation rates, as well as CL and circulating P4 volume in
diestrus subsequent to TAI application - these conditions
are essential to embryonic formation and survival [30, 4452].
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Finally, the results of the present study corroborate
the hypothesis that the different estradiol esters and eCG
adminstration differentially regulate vascularization,
steroidogenesis, and utero-ovarian gene expression in Bos
indicus cows submitted to TAI protocols.
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